{
    "code": "52026914",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026914",
    "time": "2021-01-15 03:11:28",
    "許可證字號": "衛部藥輸字第026914號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/07\/28",
    "發證日期": "105\/07\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202691400",
    "中文品名": "艾卡培&quot;艾威群&quot;膜衣錠500毫克",
    "英文品名": "Capecitabine Alvogen 500mg Film-Coated Tablets",
    "適應症": "可治療轉移性大腸（結腸直腸）癌病患。可作為第三期結腸癌患者手術後的輔助性療法。Capecitabine與Docetaxel併用於治療對Anthracyline化學治療無效之局部晚期或轉移性乳癌病患。亦可單獨用於對紫杉醇（Taxane）及Anthracyline化學治療無效，或無法使用Anthracyline治療之局部晚期或轉移性乳癌病患。Capecitabine合併Platinum可使用於晚期胃癌之第一線治療。",
    "劑型": "116膜衣錠",
    "包裝": "8-1000錠ALU-PVC-PE-PVDC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CAPECITABINE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCY0005100  REMEDICA LTD.",
            "製造廠廠址": "AHARNON STREET, LIMASSOL INDUSTRIAL ESTATE , LIMASSOL 3056, CYPRUS",
            "製造廠公司地址": "",
            "製造廠國別": "CYPRUS",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037200",
            "成分名稱": "CAPECITABINE",
            "含量描述": "",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "1-1-藥品包裝與外觀-105-09-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026914&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Capecitabine PIL_ArtworkProof_Round_4_ARTDB018487P-109-12-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026914&Seq=004&Type=9"
        },
        {
            "title": "Capecitabine_Round_2_ARTDB016774F_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026914&Seq=006&Type=8"
        },
        {
            "title": "Capecitabine_Round_2_ARTDB016773C_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026914&Seq=005&Type=8"
        },
        {
            "title": "06. Carton-ArtworkProof_CompID_13827_Round_2-107-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026914&Seq=004&Type=8"
        }
    ]
}